Trials / Completed
CompletedNCT06725992
Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR
A Randomized, Open-label, Multiple-dose, Crossover Phase 1 Clinical Trial to Compare and Evaluate the Safety, PK and PD Characteristics After Oral Administration of IY-NS250 and IY-NT-SR in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Il-Yang Pharm. Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study comparative evaluation of safety and pharmacokinetic and pharmacodynamic properties in oral repeat administration of IY-NS250 and IY-NT-SR in healthy adult
Detailed description
Not provided
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IY-NS250 | Ilaprazole 20mg + Sodium bicarbonate 500mg |
| DRUG | IY-NT-SR | Ilaprazole 10mg |
Timeline
- Start date
- 2024-01-30
- Primary completion
- 2024-04-13
- Completion
- 2024-08-14
- First posted
- 2024-12-10
- Last updated
- 2024-12-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06725992. Inclusion in this directory is not an endorsement.